Aurigene Oncology Limited, a subsidiary of Dr Reddy’s Laboratories Limited, is dedicated to developing innovative treatments for cancer and has released phase 1 findings for DRL-1801 in the SWASTH study - India's initial trial for a new CAR-T cell...
Boehringer Ingelheim, a biopharmaceutical company involved in human and animal health, revealed that the FDA has given Breakthrough Therapy status to survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist for treating adults with non...
GE Healthcare, a top international company in medical technology, pharmaceutical diagnostics, and digital solutions, has finished the first stage of testing for a unique MRI contrast agent made from manganese. According to an abstract presented at...
In an exclusive interview with India Pharma Outlook, DileepMangsuli, Senior Vice President of Global Access to Care at Siemens Healthineers, shared his views on how AI can transform personalized healthcare. AI, he emphasizes a dual-layer approach....
TiumBio Co., Ltd, a company specializing in biopharmaceuticals in the clinical development stage, revealed that the initial participant has been administered in the phase 2 clinical study of TU2218. TU2218 is a new oral inhibitor that targets both...
Sapience Therapeutics, Inc., a biotechnology company in the clinical stage, has reported the enrollment of the initial patient in its phase 2 dose expansion study for ST316, the company's innovative antagonist of b-catenin. The study's phase 1...
Merck, also recognized as MSD in countries other than the United States and Canada, revealed the finalization of the acquisition of CN201 from Curon Biopharmaceutical (Curon), a new experimental bispecific antibody in clinical development for...
The World Health Organization (WHO) issued guidance on how to enhance the organization and supervision of clinical trials in nations with diverse income levels. This guidance seeks to enhance country-led R&D ecosystems in order to progress health...
Innate Pharma SA, a worldwide biotech firm in clinical stages advancing cancer immunotherapies, reported that the FDA has approved its IND application for a phase 1 clinical trial of IPH4502, a unique topoisomerase I inhibitor ADC targeting...
The government is considering overseeing the quality of imported medical devices through a risk-based method in which random samples will be selected for quality testing, with entire shipments of critical diagnostic kits being...
, CDSCO.jpg)
